Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
20.11. | MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs | ||
20.11. | Telehealth Advocates Praise DEA's 3rd Extension of Telemedicine Flexibilities, but Call for Further Action | ||
19.11. | Ex-Invitae Spinoff Relaunches as Citizen Health, Picks Up $14.5M in Seed Funding | ||
19.11. | Merck Gets a Shot of Confidence From Pivotal Test of SubQ Injectable Keytruda | ||
19.11. | The Role of Clinical Collaboration Platforms in Enhancing Sepsis Care Workflows | ||
19.11. | Managing the Specialty Drug Cost Challenge: Is Your Pharmacy Benefits Strategy Ready for 2025? | ||
19.11. | How Emory's New Partnership Seeks to Scale Value-Based Care Across Georgia | ||
19.11. | Evvy Introduces Treatments for Common Vaginal Symptoms | ||
18.11. | Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval | ||
18.11. | Why AI Won't Replace Human Psychotherapists | ||
18.11. | Why We Urgently Need More Widely Available Tests for Alzheimer's Disease | ||
18.11. | Market Trends to Watch for Health Systems and Their Specialty Pharmacies | ||
17.11. | GSK Wagers $80M on a Tech Platform and Parkinson's Drug from Flagship-Founded Vesalius | ||
17.11. | Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema | ||
17.11. | 7 States Passed Abortion Rights Ballot Measures. But Changes Won't be Like a "Light Switch," Experts Say | ||
17.11. | Don't Erode Medical Device Trust with Right to Repair | ||
15.11. | Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec | ||
15.11. | Remote Patient Monitoring Works … What are Payers and Providers Waiting for? | ||
15.11. | Centering Caregiver and Provider Feedback in Home-Based Care Innovation | ||
14.11. | PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain | ||
14.11. | Video: What Would Happen If Prior Authorization Went Away? | ||
14.11. | CEO of Otsuka North America: Are We Getting better access with AI? | ||
14.11. | Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda | ||
14.11. | Unlocking Hidden Revenue: Transforming RCM Challenges into Financial Wins | ||
14.11. | Every Lab Can Go Greener With These Key Steps |